SK Plasma Co., Ltd.

4 clinical trials · Sponsor

Record	Firm	Date
An Open-label Study Evaluating the Efficacy, Safety, Pharmacokinetics, and Immunogenicity of SKP-0141 for the Treatment and Prophylaxis in Severe Hemophilia a Patients (NCT06738901)	SK Plasma Co., Ltd.	2025-03-31
A Clinical Study to Evaluate the Efficacy and Safety of LIV-GAMMA SN Inj. in ABO-Incompatible Liver Transplantation (NCT05666453)	SK Plasma Co., Ltd.	2022-04-25
A Clinical Study to Evaluate the Efficacy and Safety of LIV-GAMMA SN Inj.10% in Primary Immune Thrombocytopenia (ITP) (NCT05566990)	SK Plasma Co., Ltd.	2019-07-19
A Clinical Study to Evaluate the Efficacy and Safety of LIV-GAMMA SN Inj. in Primary Immune Thrombocytopenia (ITP) (NCT03164915)	SK Plasma Co., Ltd.	2016-10-24

Every clearance here is in the API, with alerts when new ones post.